Gemlapodect
1-methyl-4-(morpholine-4-carbonyl)-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyrazole-5-carboxamide
Molecular Identity
Gemlapodect
1-methyl-4-(morpholine-4-carbonyl)-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyrazole-5-carboxamide
PubChem CID: 57377410
2D Structure
Properties
C22H21N7O3
Molecular Formula
431.40
Molecular Weight
g/mol
431.1706
Exact Mass
Da
1
XLogP
Drug-like (Lipinski: < 5)
107
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
6
H-Bond Acceptors
682
Complexity
SMILES
Canonical SMILES
SMILES: CN1C(=C(C=N1)C(=O)N2CCOCC2)C(=O)NC3=CC4=NC(=NN4C=C3)C5=CC=CC=C5Isomeric SMILES
SMILES: CN1C(=C(C=N1)C(=O)N2CCOCC2)C(=O)NC3=CC4=NC(=NN4C=C3)C5=CC=CC=C5Synonyms(20)
Gemlapodect1380329-87-2RF3JGD64ZURefChem:1085744NOE-1051-methyl-4-(morpholine-4-carbonyl)-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-5-carboxamidegemlapodect [INN]Gemlapodect (USAN/INN)GEMLAPODECT [USAN]orb1738658SCHEMBL9108382CHEMBL5314465MMCSMWHWVGGCGL-UHFFFAOYSA-NGLXC-26889EX-A12261
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Gemlapodect
Loading drug network...